Together, UiPath and Deloitte will help organizations accelerate testing with agentic AI for enhanced resilience and innovation, enabling continuous autonomous quality UiPath (NYSE: PATH), a leader in ...
NEW YORK--(BUSINESS WIRE)-- UiPath (PATH), a global leader in agentic automation, today announced it has joined the Veeva AI Partner Program. As part of the program, UiPath will help simplify and ...
UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been named a Leader in The Forrester Wave(TM): Autonomous Testing Platforms, Q4 2025, reinforcing the company's ...
(RTTNews) - UiPath Inc. (PATH) surged 23.79%, climbing $3.54 to $18.40, after announcing its entry into the Veeva AI Partner Program, which will integrate UiPath's automation platform with Veeva's ...
Continuing its evolution from a robotic process automation provider to an agentic artificial intelligence platform, UiPath Inc. today unveiled a series of new capabilities designed to simplify the ...
UiPath Inc. (NYSE: PATH) is one of the best AI stocks under $50 to buy right now. On May 5, UiPath announced the expansion of ...
UiPath expanded its Test Cloud offering with new agentic testing capabilities and performance testing tools. The platform now supports exploratory testing agents to uncover edge cases, a healing agent ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leader in agentic business orchestration, today announced the release of agentic AI capabilities on UiPath Automation Suite™. The Automation Suite ...
Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project reveals how documentation quality, governance, and executive discipline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results